Do analysts prefer NSPR or INGN?

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 405.62%. Given InspireMD's stronger consensus rating and higher probable upside, equities research analysts clearly believe InspireMD is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has higher valuation & earnings, NSPR or INGN?

InspireMD has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InspireMD $10.84M 3.82 -$19.92M -$0.64 N/A Inogen $348.67M 0.42 -$22.75M -$0.90 N/A

Is NSPR or INGN more profitable?

Inogen has a net margin of -6.94% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -13.17% beat InspireMD's return on equity. Company Net Margins Return on Equity Return on Assets InspireMD -413.96% -69.42% -57.68% Inogen -6.94% -13.17% -8.36%

Which has better valuation and earnings, APYX or NSPR?

Apyx Medical has higher revenue and earnings than InspireMD. Apyx Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apyx Medical $52.84M 2.43 -$11.21M -$0.20 N/A InspireMD $10.84M 3.82 -$19.92M -$0.64 N/A

Is APYX or NSPR more profitable?

Apyx Medical has a net margin of -14.78% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Apyx Medical's return on equity. Company Net Margins Return on Equity Return on Assets Apyx Medical -14.78% -76.60% -13.91% InspireMD -413.96% -69.42% -57.68%

Do analysts recommend NSPR or KEQU?

InspireMD currently has a consensus target price of $4.50, suggesting a potential upside of 405.62%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InspireMD 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

InspireMD (NSPR) Competitors

$0.89 -0.03 (-3.28%)

As of 03:59 PM Eastern

Compare

NSPR vs. KRMD, INGN, APYX, KEQU, and MBOT

Should you buy InspireMD stock or one of its competitors? InspireMD's main competitors and comparable companies include KORU Medical Systems (KRMD), Inogen (INGN), Apyx Medical (APYX), Kewaunee Scientific (KEQU), and Microbot Medical (MBOT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does InspireMD compare to KORU Medical Systems?

InspireMD (NYSE:NSPR) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 25.0% of InspireMD shares are owned by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

InspireMD has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

KORU Medical Systems has a net margin of -4.03% compared to InspireMD's net margin of -413.96%. KORU Medical Systems' return on equity of -10.63% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

In the previous week, KORU Medical Systems had 4 more articles in the media than InspireMD. MarketBeat recorded 4 mentions for KORU Medical Systems and 0 mentions for InspireMD. KORU Medical Systems' average media sentiment score of 1.22 beat InspireMD's score of 1.00 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
InspireMD	Positive
KORU Medical Systems	Positive

KORU Medical Systems has higher revenue and earnings than InspireMD. KORU Medical Systems is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.82	-$19.92M	-$0.64	N/A
KORU Medical Systems	$41.13M	3.58	-$2.64M	-$0.04	N/A

InspireMD presently has a consensus price target of $4.50, suggesting a potential upside of 405.62%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 118.07%. Given InspireMD's stronger consensus rating and higher probable upside, equities research analysts plainly believe InspireMD is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

KORU Medical Systems beats InspireMD on 10 of the 16 factors compared between the two stocks.

How does InspireMD compare to Inogen?

InspireMD (NYSE:NSPR) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

InspireMD has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market. Comparatively, Inogen has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market.

44.8% of InspireMD shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 25.0% of InspireMD shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Inogen has a net margin of -6.94% compared to InspireMD's net margin of -413.96%. Inogen's return on equity of -13.17% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Inogen	-6.94%	-13.17%	-8.36%

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 405.62%. Given InspireMD's stronger consensus rating and higher probable upside, equities research analysts clearly believe InspireMD is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, Inogen had 1 more articles in the media than InspireMD. MarketBeat recorded 1 mentions for Inogen and 0 mentions for InspireMD. InspireMD's average media sentiment score of 1.00 beat Inogen's score of 0.93 indicating that InspireMD is being referred to more favorably in the media.

Company	Overall Sentiment
InspireMD	Positive
Inogen	Positive

InspireMD has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.82	-$19.92M	-$0.64	N/A
Inogen	$348.67M	0.42	-$22.75M	-$0.90	N/A

Summary

InspireMD beats Inogen on 9 of the 17 factors compared between the two stocks.

How does InspireMD compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

Apyx Medical has a beta of 1.39, suggesting that its stock price is 39% more volatile than the broader market. Comparatively, InspireMD has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Apyx Medical presently has a consensus price target of $6.60, suggesting a potential upside of 116.39%. InspireMD has a consensus price target of $4.50, suggesting a potential upside of 405.62%. Given InspireMD's stronger consensus rating and higher probable upside, analysts plainly believe InspireMD is more favorable than Apyx Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Apyx Medical has higher revenue and earnings than InspireMD. Apyx Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.43	-$11.21M	-$0.20	N/A
InspireMD	$10.84M	3.82	-$19.92M	-$0.64	N/A

Apyx Medical has a net margin of -14.78% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
InspireMD	-413.96%	-69.42%	-57.68%

In the previous week, Apyx Medical had 1 more articles in the media than InspireMD. MarketBeat recorded 1 mentions for Apyx Medical and 0 mentions for InspireMD. Apyx Medical's average media sentiment score of 1.89 beat InspireMD's score of 1.00 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Very Positive
InspireMD	Positive

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 44.8% of InspireMD shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 25.0% of InspireMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Apyx Medical beats InspireMD on 11 of the 17 factors compared between the two stocks.

How does InspireMD compare to Kewaunee Scientific?

InspireMD (NYSE:NSPR) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

InspireMD currently has a consensus target price of $4.50, suggesting a potential upside of 405.62%. Given InspireMD's stronger consensus rating and higher probable upside, analysts clearly believe InspireMD is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

InspireMD has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market.

44.8% of InspireMD shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 25.0% of InspireMD shares are owned by company insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Kewaunee Scientific has higher revenue and earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.82	-$19.92M	-$0.64	N/A
Kewaunee Scientific	$282M	0.39	$9.62M	$3.22	11.76

Kewaunee Scientific has a net margin of 3.41% compared to InspireMD's net margin of -413.96%. Kewaunee Scientific's return on equity of 14.10% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Kewaunee Scientific	3.41%	14.10%	5.55%

In the previous week, Kewaunee Scientific had 3 more articles in the media than InspireMD. MarketBeat recorded 3 mentions for Kewaunee Scientific and 0 mentions for InspireMD. InspireMD's average media sentiment score of 1.00 beat Kewaunee Scientific's score of 0.87 indicating that InspireMD is being referred to more favorably in the media.

Company	Overall Sentiment
InspireMD	Positive
Kewaunee Scientific	Positive

Summary

InspireMD and Kewaunee Scientific tied by winning 8 of the 16 factors compared between the two stocks.

How does InspireMD compare to Microbot Medical?

InspireMD (NYSE:NSPR) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

44.8% of InspireMD shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 25.0% of InspireMD shares are held by company insiders. Comparatively, 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

InspireMD has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market.

InspireMD currently has a consensus target price of $4.50, suggesting a potential upside of 405.62%. Microbot Medical has a consensus target price of $6.38, suggesting a potential upside of 319.41%. Given InspireMD's stronger consensus rating and higher probable upside, research analysts plainly believe InspireMD is more favorable than Microbot Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InspireMD	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Microbot Medical has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. Microbot Medical's return on equity of -21.87% beat InspireMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InspireMD	-413.96%	-69.42%	-57.68%
Microbot Medical	N/A	-21.87%	-20.76%

In the previous week, Microbot Medical had 12 more articles in the media than InspireMD. MarketBeat recorded 12 mentions for Microbot Medical and 0 mentions for InspireMD. InspireMD's average media sentiment score of 1.00 beat Microbot Medical's score of -0.64 indicating that InspireMD is being referred to more favorably in the media.

Company	Overall Sentiment
InspireMD	Positive
Microbot Medical	Negative

Microbot Medical has lower revenue, but higher earnings than InspireMD. Microbot Medical is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InspireMD	$10.84M	3.82	-$19.92M	-$0.64	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.24	N/A

Summary

InspireMD and Microbot Medical tied by winning 7 of the 14 factors compared between the two stocks.

Get InspireMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NSPR vs. The Competition

Export

Metric	InspireMD	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$41.38M	$5.94B	$7.40B	$24.35B
Dividend Yield	N/A	1.75%	2.53%	3.70%
P/E Ratio	-1.19	21.41	212.23	26.24
Price / Sales	3.82	69.39	630.33	20.88
Price / Cash	N/A	33.21	79.89	33.34
Price / Book	0.49	6.24	13.14	7.69
Net Income	-$19.92M	$149.10M	$3.47B	$1.07B
7 Day Performance	-2.19%	0.53%	1.38%	-0.21%
1 Month Performance	30.19%	9.26%	8.62%	2.84%
1 Year Performance	-63.97%	6.82%	25.90%	14.58%

InspireMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NSPR InspireMD	3.8206 of 5 stars	$0.89 -3.3%	$4.50 +405.6%	-61.7%	$41.38M	$10.84M	N/A	50	Positive News
KRMD KORU Medical Systems	4.1346 of 5 stars	$3.33 -0.9%	$7.00 +110.2%	-23.6%	$156.17M	$41.13M	N/A	80
INGN Inogen	1.0293 of 5 stars	$5.60 -1.9%	N/A	-28.1%	$152.60M	$348.67M	N/A	1,030
APYX Apyx Medical	3.4453 of 5 stars	$3.11 +1.6%	$6.60 +112.2%	+51.0%	$127.64M	$52.84M	N/A	270
KEQU Kewaunee Scientific	1.2209 of 5 stars	$36.01 -0.9%	N/A	-33.2%	$104.71M	$282M	11.18	1,231	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NSPR) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InspireMD (NSPR) Competitors

NSPR vs. KRMD, INGN, APYX, KEQU, and MBOT

How does InspireMD compare to KORU Medical Systems?

Summary

How does InspireMD compare to Inogen?

Summary

How does InspireMD compare to Apyx Medical?

Summary

How does InspireMD compare to Kewaunee Scientific?

Summary

How does InspireMD compare to Microbot Medical?

Summary

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InspireMD (NSPR) Competitors

NSPR vs. KRMD, INGN, APYX, KEQU, and MBOT

How does InspireMD compare to KORU Medical Systems?

Do insiders & institutionals hold more shares of NSPR or KRMD?

Which has more volatility & risk, NSPR or KRMD?

Is NSPR or KRMD more profitable?

Does the media refer more to NSPR or KRMD?

Which has higher valuation and earnings, NSPR or KRMD?

Do analysts rate NSPR or KRMD?

Summary

How does InspireMD compare to Inogen?

Which has more volatility & risk, NSPR or INGN?

Do insiders and institutionals have more ownership in NSPR or INGN?

Is NSPR or INGN more profitable?

Do analysts prefer NSPR or INGN?

Does the media favor NSPR or INGN?

Which has higher valuation & earnings, NSPR or INGN?

Summary

How does InspireMD compare to Apyx Medical?

Which has more volatility and risk, APYX or NSPR?

Do analysts rate APYX or NSPR?

Which has better valuation and earnings, APYX or NSPR?

Is APYX or NSPR more profitable?

Does the media favor APYX or NSPR?

Do insiders and institutionals have more ownership in APYX or NSPR?

Summary

How does InspireMD compare to Kewaunee Scientific?

Do analysts recommend NSPR or KEQU?

Which has more volatility & risk, NSPR or KEQU?

Do institutionals and insiders hold more shares of NSPR or KEQU?

Which has better earnings and valuation, NSPR or KEQU?

Is NSPR or KEQU more profitable?

Does the media prefer NSPR or KEQU?

Summary

How does InspireMD compare to Microbot Medical?

Do institutionals & insiders have more ownership in NSPR or MBOT?

Which has more volatility and risk, NSPR or MBOT?

Do analysts recommend NSPR or MBOT?

Is NSPR or MBOT more profitable?

Does the media favor NSPR or MBOT?

Which has better earnings and valuation, NSPR or MBOT?

Summary

Media Sentiment Over Time

NSPR vs. The Competition

InspireMD Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools